![Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial | SpringerLink Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00213-004-1957-9/MediaObjects/s00213-004-1957-9fhc2.jpg)
Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial | SpringerLink
![Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder | Scientific Reports Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep28028/MediaObjects/41598_2016_Article_BFsrep28028_Fig1_HTML.jpg)
Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder | Scientific Reports
![PDF] Early relief of pain symptoms predicts the improvement of anxiety in generalized anxiety disorder patients with painful physical symptoms receiving venlafaxine treatment | Semantic Scholar PDF] Early relief of pain symptoms predicts the improvement of anxiety in generalized anxiety disorder patients with painful physical symptoms receiving venlafaxine treatment | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5eb410580266e3e565e7b7f1eec0c5158d853545/5-Table4-1.png)
PDF] Early relief of pain symptoms predicts the improvement of anxiety in generalized anxiety disorder patients with painful physical symptoms receiving venlafaxine treatment | Semantic Scholar
![Efficacy and Safety of Extended-Release Venlafaxine in the Treatment of Generalized Anxiety Disorder in Children and Adolescents: Two Placebo-Controlled Trials | American Journal of Psychiatry Efficacy and Safety of Extended-Release Venlafaxine in the Treatment of Generalized Anxiety Disorder in Children and Adolescents: Two Placebo-Controlled Trials | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/ajp.2007.164.2.290/asset/images/medium/r421f3.jpeg)
Efficacy and Safety of Extended-Release Venlafaxine in the Treatment of Generalized Anxiety Disorder in Children and Adolescents: Two Placebo-Controlled Trials | American Journal of Psychiatry
![Efficacy of Extended-Release Venlafaxine in Nondepressed Outpatients With Generalized Anxiety Disorder | American Journal of Psychiatry Efficacy of Extended-Release Venlafaxine in Nondepressed Outpatients With Generalized Anxiety Disorder | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/appi.ajp.157.6.968/asset/images/medium/az18f2.jpeg)